{
    "nctId": "NCT00502567",
    "officialTitle": "A Phase 1, Open Label Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2171 and Selected Chemotherapy Regimens When Given in Combination to Patients With Advanced Solid Tumors",
    "inclusionCriteria": "* histologically confirmed metastatic cancer that is not amenable to surgery or radiation therapy with curative intent\n* measurable lesion by CT or other techniques according to RECIST\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Inadequate bone marrow reserve\n* history of poorly controlled hypertension"
}